Drug · DIN 02415968
REPAGLINIDE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 16, 2016; first marketed November 28, 2013.
- Drug Identification Number (DIN)
- 02415968
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Repaglinide A10BX02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| REPAGLINIDE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 16, 2016: NOC 18782Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- November 26, 2013: NOC 14945Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named REPAGLINIDE
- DIN 02415976 · Marketed
- DIN 02415984 · Marketed